Conference Reports for NATAP
13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil
Back
Favorable Tolerability of Lenacapavir for PrEP Administered at Participant-Chosen Anatomic Sites in PURPOSE 1 and PURPOSE 2
IAS 2026 Rio, Brazil